These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32692486)

  • 41. China's evolving biosafety/biosecurity legislations.
    Cao C
    J Law Biosci; 2021; 8(1):lsab020. PubMed ID: 34221436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Brazilian High- and Maximum-Containment Laboratories Biosafety and Biosecurity Regulations to Legal Frameworks in the United States and Other Countries: Gaps and Opportunities.
    Mendonça AO; Zuelke KA; Kahl-Mcdonagh MM; Mafra C
    Appl Biosaf; 2024 Mar; 29(1):45-56. PubMed ID: 38434103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication.
    Dickmann P; Apfel F; Biedenkopf N; Eickmann M; Becker S
    Health Secur; 2015; 13(2):88-95. PubMed ID: 25813975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biosafety and Biosecurity in Containment: A Regulatory Overview.
    Beeckman DSA; Rüdelsheim P
    Front Bioeng Biotechnol; 2020; 8():650. PubMed ID: 32719780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative impact of laws regarding biosecurity and bioterrorism on real diseases.
    Wurtz N; Grobusch MP; Raoult D
    Clin Microbiol Infect; 2014 Jun; 20(6):507-15. PubMed ID: 24909400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
    Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
    Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of an outbreak caused by an unknown infectious pathogen in rural Zola.
    Aku FY; Beisembekova D; Adebisi NA; Mertens E; Wende L; Marashi SM; Dywicki J
    Pan Afr Med J; 2021; 40(Suppl 2):5. PubMed ID: 36285253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biosecurity Assessments for Emerging Transdisciplinary Biotechnologies: Revisiting Biodefense in an Age of Synthetic Biology.
    DiEuliis D; Imperiale MJ; Berger KM
    Appl Biosaf; 2024 Sep; 29(3):123-132. PubMed ID: 39372508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investment in biosafety and biosecurity: the need for a risk-based approach and systematic reporting of laboratory accidents to mitigate laboratory-acquired infections and pathogen escapes.
    Blacksell SD; Summermatter K; Masuku ZM; Kojima K; Ross E; Harper DR; Hamilton K
    Lancet Microbe; 2023 Nov; 4(11):e854-e855. PubMed ID: 37774730
    [No Abstract]   [Full Text] [Related]  

  • 50. The dual-use dilemma for the life sciences: perspectives, conundrums, and global solutions.
    Atlas RM; Dando M
    Biosecur Bioterror; 2006; 4(3):276-86. PubMed ID: 16999588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic and Synthetic Biology Digital Biosecurity.
    Hudson CM; Pattengale ND; Iyer RK; Kalbarczyk ZT; Alli N
    Pac Symp Biocomput; 2022; 27():402-406. PubMed ID: 34890167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Embrace experimentation in biosecurity governance.
    Evans SW; Beal J; Berger K; Bleijs DA; Cagnetti A; Ceroni F; Epstein GL; Garcia-Reyero N; Gillum DR; Harkess G; Hillson NJ; Hogervorst PAM; Jordan JL; Lacroix G; Moritz R; ÓhÉigeartaigh SS; Palmer MJ; van Passel MWJ
    Science; 2020 Apr; 368(6487):138-140. PubMed ID: 32273459
    [No Abstract]   [Full Text] [Related]  

  • 53. Auditing laboratory rodent biosecurity programs.
    Porter WP; Horn MJ; Cooper DM; Klein HJ
    Lab Anim (NY); 2013 Oct; 42(11):427-31. PubMed ID: 24150170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Context matters: On the road to responsible biosafety technologies in synthetic biology.
    Kallergi A; Asin-Garcia E; Martins Dos Santos VA; Landeweerd L
    EMBO Rep; 2021 Jan; 22(1):e51227. PubMed ID: 33369847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dimensional analysis of the concept of biosafety due to bioterrorism].
    Bernard L; Shaha M
    Rech Soins Infirm; 2014 Mar; (116):13-27. PubMed ID: 24830220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Introduction to ISBGMO12: biosafety research past, present and future.
    Raybould A; Quemada H; Romeis J
    Transgenic Res; 2014 Dec; 23(6):911-4. PubMed ID: 24823764
    [No Abstract]   [Full Text] [Related]  

  • 58. Promoting biosecurity by professionalizing biosecurity.
    Moritz RL; Berger KM; Owen BR; Gillum DR
    Science; 2020 Feb; 367(6480):856-858. PubMed ID: 32079762
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.